SCFAs have been shown to induce excessive production of IL-8 in CF epithelium cell lines [88], and while using SCFAs therapeutically in CF is unlikely, disrupting cross-feeding mechanisms may reduce P. aeruginosa fitness. The gene discussed is CXCL8; the disease is cystic fibrosis.